ATE216254T1 - Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure - Google Patents

Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure

Info

Publication number
ATE216254T1
ATE216254T1 AT97924958T AT97924958T ATE216254T1 AT E216254 T1 ATE216254 T1 AT E216254T1 AT 97924958 T AT97924958 T AT 97924958T AT 97924958 T AT97924958 T AT 97924958T AT E216254 T1 ATE216254 T1 AT E216254T1
Authority
AT
Austria
Prior art keywords
alpha
carrier
pharmaceutical compositions
compositions containing
ester
Prior art date
Application number
AT97924958T
Other languages
English (en)
Inventor
Alberto Salini
Original Assignee
Flarer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flarer S A filed Critical Flarer S A
Application granted granted Critical
Publication of ATE216254T1 publication Critical patent/ATE216254T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97924958T 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure ATE216254T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
PCT/EP1997/002553 WO1997044053A1 (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid

Publications (1)

Publication Number Publication Date
ATE216254T1 true ATE216254T1 (de) 2002-05-15

Family

ID=11374287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924958T ATE216254T1 (de) 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure

Country Status (12)

Country Link
US (1) US6194401B1 (de)
EP (1) EP0901378B1 (de)
JP (1) JP2000510857A (de)
AT (1) ATE216254T1 (de)
AU (1) AU709068B2 (de)
CA (1) CA2255640A1 (de)
DE (1) DE69712055D1 (de)
IL (1) IL127154A0 (de)
IT (1) IT1282733B1 (de)
NZ (1) NZ332904A (de)
WO (1) WO1997044053A1 (de)
ZA (1) ZA974356B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10038699A1 (de) * 2000-07-31 2002-02-14 Michael Sittinger Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
KR100966627B1 (ko) * 2006-06-14 2010-06-29 주식회사 대웅제약 L-α-글리세로포스포릴 콜린의 제조방법
ES2575565T3 (es) * 2008-05-08 2016-06-29 United Therapeutics Corporation Procedimiento para la preparación de monohidrato de treprostinilo y su utilización para el almacenamiento y el envío
WO2010141068A1 (en) * 2009-06-02 2010-12-09 Wu Nian Opthalmic compositions of cyclosporin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515035A1 (fr) 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
JPS5916818A (ja) 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
IT1265647B1 (it) 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
EP0697214A1 (de) * 1994-07-19 1996-02-21 Vestar, Inc. Pharmazeutische Formulierungen mit liposomalem Cyclosporin

Also Published As

Publication number Publication date
NZ332904A (en) 2000-06-23
EP0901378B1 (de) 2002-04-17
AU709068B2 (en) 1999-08-19
ITMI961010A1 (it) 1997-11-20
ITMI961010A0 (de) 1996-05-20
ZA974356B (en) 1998-01-14
US6194401B1 (en) 2001-02-27
IL127154A0 (en) 1999-09-22
CA2255640A1 (en) 1997-11-27
IT1282733B1 (it) 1998-03-31
JP2000510857A (ja) 2000-08-22
EP0901378A1 (de) 1999-03-17
AU3027697A (en) 1997-12-09
DE69712055D1 (de) 2002-05-23
WO1997044053A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ATA192293A (de) Cyclosporin enthaltende pharmazeutische zusammensetzungen
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE69713148D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
TR199900239T2 (de)
TNSN98075A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
BR9707333A (pt) Dihidrobenzofurano e compostos relacionados úteis como agentes antinflamatórios
SE9504661D0 (sv) New compounds
ATE173402T1 (de) Lyophilisierte stammzellenfaktor formulierungen
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
BG103664A (en) Pharmaceutical forms containing ammoxycillin and clavulanate
ZA200110000B (en) Novel preparation and administration form comprising an acid-labile active compound.
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
ES2167751T3 (es) Preparaciones de insulina conteniendo un halogenuro.
EA200400041A1 (ru) Сочетание действующих ингредиентов, используемое в качестве вызывающего привыкание фармакологического средства или для интоксикационной терапии
ATE216254T1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
ES2133295T3 (es) Peptidos ciclicos y su uso.
DE60043442D1 (de) Ner aktiven phase und einer inaktiven phase
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE259244T1 (de) Vermeidung von gastrointestinaler schädigung
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
BR9707342A (pt) Dihidrobensofurano e compostos correlatod úteis como agentes antiinflamatórios
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TR199900013T2 (xx) Yeni bile�ikler.
DE69804674D1 (de) Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties